These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: HPV, vaccines, and cervical cancer in a low- and middle-income country.
    Author: Petersen LM, Fenton JM, Kennedy LS, LaRochelle EPM, Bejarano S, Tsongalis GJ.
    Journal: Curr Probl Cancer; 2020 Dec; 44(6):100605. PubMed ID: 32507365.
    Abstract:
    Real-world conditions test effectiveness, the next step after establishing efficacy in controlled settings. From the annual flu shot to HPV vaccination, effectiveness measures what happens when best efforts for vaccine development meet the realities of challenging viruses and changing subtypes in regions around the world. After testing 2,645 women from multiple locations in Honduras for types of high-risk HPV (hrHPV) and finding the prevalence of virus types to be quite different from those in the US, we asked what vaccine would be the most efficacious for the local situation, and which hrHPV types are most commonly found in cervical cancer tissues from Honduran women.
    [Abstract] [Full Text] [Related] [New Search]